A selection of presentations that will be given by SFARI Investigators at the 2017 International Meeting for Autism Research (IMFAR) in San Francisco (May 10-13) is highlighted below.
Leonard Abbeduto, Ph.D. (University of California, Davis)
Panel session presentation:
Understanding the comorbidity of autism spectrum disorder and fragile X syndrome: Moving beyond a categorical approach
Steven Chance, Ph.D. (University of Oxford)
Panel session presentation:
Altered cellular organisation in the cerebral cortex: A new imaging measure of cortical microstructure to meet the challenge of heterogeneity in autism
Wendy Chung, M.D., Ph.D. (Simons Foundation/ Columbia University)
Sponsor presentation:
Simons Foundation update
Lisa Croen, Ph.D. (Kaiser Permanente Northern California)
Oral session presentation:
Medical conditions in the first years of life associated with future diagnosis of
ASD in children
William Gaetz, Ph.D. (The Children’s Hospital of Philadelphia)
Oral session presentation:
Neuromagnetic responses to tactile stimulation of the fingers: Evidence for reduced cortical inhibition for children with autism and children with epilepsy
Matthew Goodwin, Ph.D. (Northeastern University)
Panel session presentation:
Wearable sensor-based physiological and physical activity biomarkers for use in laboratory and naturalistic environments to assess arousal and repetitive motor movements in individuals with autism spectrum disorder
Ami Klin, Ph.D. and Warren Jones, Ph.D. (Emory University)
Keynote presentation:
Developmental endophenotypes to quantify the emergence of autism in infancy
Karen Parker, Ph.D. (Stanford University)
Oral session presentation:
Intranasal vasopressin treatment improves social abilities in children with autism
Karen Pierce, Ph.D. (University of California, San Diego)
Oral session presentation:
The fluid nature of the very early ASD phenotype: Examination of diagnostic stability of ASD within a general population cohort
Timothy Roberts, Ph.D. (Children’s Hospital of Philadelphia)
Oral session presentation:
Decoupling of the GABA/gamma relationship during development in ASD – the impact of an atypical developmental trajectory
Stephan Sanders, B.M.B.S., Ph.D. (University of California, San Francisco)
Panel session presentation:
Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures
Oral session presentation:
Interaction between human sexual dimorphism and ASD neurobiology
Frederick Shic, Ph.D. (Seattle Children’s Research Institute/ University of Washington)
Panel session presentation:
Eye tracking as a spectrum of biomarkers in children with ASD
Matthew Siegel, M.D. (Maine Medical Center Research Institute)
Panel session presentation:
Talking about death or suicide: Prevalence and clinical correlates in youth with autism spectrum disorder
Holly Stessman, Ph.D. (Creighton University)
Panel session presentation:
Targeted sequencing identifies 90 neurodevelopmental disorder risk genes with autism and developmental disability biases
Lauren Weiss, Ph.D. (University of California, San Francisco)
Oral session presentation:
Maternal and fetal genetic control of mid-gestational and neonatal levels of markers of immune function
